Hao Cheng
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Molecular Medicine top 1%
Papers in
- Biomaterials 13
- Nanoparticle-Based Drug Delivery 9
-
- RNA Interference and Gene Delivery 10
- Heat shock proteins research 8
- Single-cell and spatial transcriptomics 5
- Journals
- Advanced Materials (6 papers)ACS Nano (4 papers)Theranostics (4 papers)Journal of Medicinal Chemistry (4 papers)Biomaterials (4 papers)
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
Hao Cheng
87 papers receiving 5.0k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Biomaterials 1.4k
- Molecular Medicine 307
- Pharmaceutical Science 350
- Biomedical Engineering 2.2k
- Immunology 672
Countries citing papers authored by Hao Cheng
This map shows the geographic impact of Hao Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Cheng more than expected).
Fields of papers citing papers by Hao Cheng
This network shows the impact of papers produced by Hao Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Cheng. The network helps show where Hao Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Hao Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 11 | |
| 4 | 2023 | 9 | |
| 5 | 2022 | 15 | |
| 6 | 2022 | 6 | |
| 7 | 2022 | 7 | |
| 8 | 2020 | 29 | |
| 9 | 2020 | 33 | |
| 10 | 2019 | 61 | |
| 11 | 2019 | 49 | |
| 12 | 2018 | 26 | |
| 13 | 2017 | 5 | |
| 14 | 2016 | 12 | |
| 15 | Fuzzy theory-based athletes professional skills comprehensive evaluation research | 2014 | 1 |
| 16 | 2014 | 197 | |
| 17 | 2014 | 54 | |
| 18 | 2011 | 36 | |
| 19 | 2006 | 42 | |
| 20 | 2006 | 13 |
About Hao Cheng
Hao Cheng is a scholar working on Biomaterials, Molecular Biology, Pharmaceutical Science, Immunology and Biomedical Engineering, having authored 92 papers that have together received 5.0k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (11 papers), RNA Interference and Gene Delivery (10 papers), Bone Tissue Engineering Materials (10 papers), Nanoparticle-Based Drug Delivery (9 papers), Heat shock proteins research (8 papers), 3D Printing in Biomedical Research (8 papers), Immunotherapy and Immune Responses (7 papers) and Single-cell and spatial transcriptomics (5 papers). The work is most often cited by research in Biomaterials (1.4k citations), Molecular Medicine (307 citations), Pharmaceutical Science (350 citations), Biomedical Engineering (2.2k citations) and Immunology (672 citations). Hao Cheng has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Zhiyuan Fan, Zhen Gu, Hao Zhou, Peter Y. Li, Róbert Langer, Tram T. Dang, Junjie Deng, Yunlong Zhang, Daniel G. Anderson and Ali Khademhosseini. Their work appears in journals such as Advanced Materials, ACS Nano, Theranostics, Journal of Medicinal Chemistry and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.